NCT03192020 2025-03-26
DETECT
Tampere University
Phase 4 Active not recruiting
Clinical Trials
11 trialsNCT02647619 2022-04-26
Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF
University Hospital, Akershus
Phase 4 Completed
NCT03331926 2020-04-22
Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Horsens Hospital
Completed
NCT01444729 2017-10-26
Post Approval Commitment Study
Endo Pharmaceuticals
Completed
NCT01407068 2017-10-05
Administration of Two Injections for Multiple Dupuytren's Contractures
Endo Pharmaceuticals
Phase 3 Completed
NCT01498640 2017-10-05
Retreatment of Recurrent Dupuytren's Contractures
Endo Pharmaceuticals
Phase 4 Completed
NCT02193828 2017-10-05
Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules
Endo Pharmaceuticals
Phase 2 Completed
NCT01588353 2017-03-21
CORD-J
Asahi Kasei Pharma Corporation
Phase 3 Completed
NCT01538017 2016-10-04
Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture
Regionshospitalet Silkeborg
Phase NA Completed
NCT02476461 2015-06-19
PNFvsxiapex
Oslo University Hospital
Phase 4 Unknown
NCT01229436 2014-03-17
POINT X
Pfizer
Phase 3 Completed